Shoulder Innovations is a medical device company exclusively focused on shoulder arthroplasty — the surgical reconstruction of the shoulder joint with prosthetic implants. The company's core product is the InSet Glenoid, a socket-side implant designed to sit within a pocket of native bone rather than on top of it, which the company argues reduces the loosening effect that is the leading cause of revision surgery in anatomic total shoulder arthroplasty. Complementing the glenoid, the company offers humeral stem implants compatible with both anatomic and reverse shoulder arthroplasty procedures, using a shared instrument set. Shoulder Innovations also offers ProVoyance, an AI-powered preoperative planning tool that converts CT scans into 3D surgical plans, provided to surgeons as part of the product ecosystem rather than as a standalone paid offering. The company sells implants to hospitals, outpatient centers, and ambulatory surgery centers (ASCs) on a procedure-by-procedure basis, with surgeons as the key decision-makers. Shoulder Innovations reaches surgeons through its own commercial team and independent distributors. The company's two-tray instrument system is a deliberate fit for ASCs, which have tighter space and logistics constraints than hospitals. Surgeon adoption depth is a key business driver, and the company tracks surgeons across three tiers based on quarterly procedure volume. Shoulder Innovations outsources manufacturing to third-party suppliers, keeping capital requirements low. The company's pipeline includes a revision system, fracture-specific implants, metal-sensitivity implants, and a shoulder-specific robotic surgery platform.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →